INSIGHTS ON ENTERPRISE SOLUTIONS

• Facing Challenges In Gene Therapy Development

  In this two-minute preview, we take a high-level look at the entire gene therapy development journey — from discovery and preclinical research to process development, manufacturing, regulatory engagement, and clinical trials.

• Quality Agreements, Tech Transfer & Risk Management In CGT

  Early quality, strong tech transfer, solid data discipline, and risk‑based decisions help accelerate advanced therapy programs and ensure compliance, scalability, and regulatory confidence.

• Getting Your Proof Of Clonality Right For Regulators

  Regulators require clear, verifiable proof that production cell lines originate from a single progenitor cell, supported by strong imaging, documentation, and data integrity to ensure product consistency and safety.

• What Makes A Cell Bank 'GMP-Ready'?

  A GMP‑ready cell bank requires controlled stability, sterility, genetic integrity, and complete documentation to ensure consistent, safe biologic production and meet regulatory expectations.

• CHO Cell Line Performance With 2G UNic® Technology

  2/27/2026

  Optimized vector designs significantly enhance CHO cell protein expression, yielding higher titers, better stability, and strong performance across diverse host lines and scale‑up stages.

• How Early Data Drives Better Cell Line Performance

  2/27/2026

  Structured early data strengthens clonality assurance, stability, and tech transfer, supporting consistent performance, lower variability, and smoother progression to manufacturing.

• USP <665> Compliance Guidance

  2/26/2026

  Experts address key USP <665> questions, including risk assessment, testing approaches, extractables and leachables, and practical challenges in implementing single‑use systems in manufacturing.

• Scaling MSC Therapies: Overcoming Cell Therapy Manufacturing Risks And Barriers

  2/26/2026

  Achieve scalable MSC manufacturing by implementing closed systems and modular scale-out strategies that minimize contamination risks and ensure consistent cellular stability and efficacy.